INTRODUCTION
The construction of an accurate family pedigree is fundamental to the provision of clinical genetic services and serves as an informational framework for human genetic research. Review of a family pedigree aids the clinician in diagnosis, helps establish the pattern of inheritance, and assists in identifying persons at risk. The pedigree also serves as a reference of social and biological relationships to alert the clinician to issues of blended families, adoption, deaths, pregnancy termination, and pregnancies conceived by assisted reproductive technologies. Correct interpretation of family pedigrees is essential for human genetic research and is particularly challenging when reviewing pedigrees diagrammed within professional publications or when research teams collaborate to study large families. Pedigree analysis also facilitates the identification of disorders where genetic mechanisms such as anticipation, mitochondrial inheritance, X-linked or dominant homozygous lethality, and differential age at onset, based on the sex of the transmitting individual, are factors.
Although one might assume that pedigree nomenclature is used in a universal fashion, we have demonstrated wide variation among genetics professionals, both in clinical practice and in professional publications. A survey of members of the National Society of Genetic Counselors (NSGC) showed discrepancies even in common symbols used to record a genetic family history (i.e., pregnancy, miscarriage, abortion, termination of pregnancy, adoption) (Bennett et al., 1993) . No consensus was noted in recording situations representing assisted reproductive technologies (i.e., artificial insemination by donor semen, donor ovum, surrogate motherhood). A review of 24 standard medical genetic textbooks and publications in ten current human genetic journals further demonstrated wide variation in pedigree construction (Steinhaus et al., in press ). Historical studies have also shown a lack of consistency in pedigree symbols throughout the twentieth century (Resta, 1993) .
Standardization of pedigree nomenclature is important, much as it was useful to develop universal cytogenetic nomenclature (Paris Conference, 1971) . The Pedigree Standardization Task Force (PSTF) was established through the Professional Issues Committee of the NSGC to address this issue and to make recommendations for standardized human pedigree nomenclature. The recommendations of the PSTF are presented here.
MATERIAL AND METHODS
A draft of proposed pedigree nomenclature was developed by reviewing symbols and abbreviations used by genetic counselors in clinical practice, on the basis of 437 questionnaire responses by NSGC members (Bennett et al., 1993) . Pedigree nomenclature in professional human genetic publications, including current journal articles and standard human genetic textbooks, was also reviewed (Steinhaus et al., in press ). In addition to frequent usage, consistency among symbols, computer compatibility, and ability to adapt to the rapid changes in human genetics were considered.
A peer review of the proposed pedigree nomenclature was conducted. A first draft of proposed symbols was circulated to a liaison committee that included representatives from the NSGC, the American Board of Medical Genetics, the American Society of Human Genetics (ASHG), the American Board of Genetic Counseling, the Washington State Department of Health, editors of various genetic publications, the Education Committee of the Council of Regional Genetics Networks (CORN), the Adoption Subcommittee of CORN, the Alliance of Genetic Support Groups, and the International Society of Nurses in Genetics. The resulting recommendations were presented in poster format at the 1993 annual education conferences of the NSGC in Atlanta and the ASHG in New Orleans, allowing participants at these meetings the opportunity to provide both verbal and written response to the PSTF. After incorporation of reviewer commentary, a revision was presented as a poster at the 1994 joint meeting of the March of Dimes Education Conference and the American College of Medical Genetics (ACMG) in Kissimmee, Florida, again allowing an opportunity for comment by practicing genetic professionals. A third revision of the pedigree nomenclature was sent, in April 1994, to ~120 genetic professionals, including journal editors, chairs of the major professional genetic societies and organizations (including the newly formed ACMG), directors of genetic counseling training programs, authors of standard human genetic textbooks, and other leaders in the field of human genetics. The proposed nomenclature was field-tested by small focus groups, including members of the Education Committees of the Pacific Northwest Regional Genetics Group and the Pacific Southwest Regional Genetics Group, and master's-level genetic counseling students at the University of Wisconsin. A fourth revision was distributed in July 1994 to -70 genetic professionals from the original list of 120. Minor revisions were made in this fourth draft, which was then submitted to, and approved by, the PSTF liaison members.
RESULTS
The NSGC PSTF's recommendations for symbolization of a genetic family history are outlined in Figs. 1-5. These recommendations apply both to unpublished clinical pedigrees and to research publication, once identifying information (i.e., birthdates, names) has been removed. The Appendix Other abbreviations (e.g., TAB, VTOR Ab) not used for sake of consistency.
Standardized Human Pedigree Nomenclature
Key/legend used to define shading. 
DISCUSSION
The pedigree is the symbolic language of clinical genetic services and of human genetic research. In this age of increasing information exchange, standardization of the language of the human pedigree is essential for clear communication among medical professionals and genetic researchers. As with the development of cytogenetic nomenclature, the development of uniform pedigree nomenclature is an evolving process. The utility and the effectiveness of the proposed pedigree nomenclature need to be evaluated in the future. Plans for assessment include review of genetic publications, in a few years time, to determine whether the symbols are indeed being used by the authors. In addition, a sample of members of the professional genetics organizations can be surveyed about the value of the pedigree nomenclature guidelines in their clinical practice and research.
There are several methods for incorporating standardized pedigree nomenclature into practice. Teaching uniform pedigree symbols in human genetic professional training programs, in medical and nursing schools, and to allied health professionals, as well as including standard pedigree nomenclature in board examinations, will encourage the next generation of health-care providers to integrate this nomenclature into their routine. If genetic diagnostic labs require standardized pedigrees on their intake and Couple in which woman is carrying pregnancy using donor egg(s) and partner's sperm.
Couple whose gametes are used to impregnate another woman (surrogate) who carries the pregnancy.
Couple in which male partner's sperm is used to inseminate a) an unrelated woman or b) a sister who is carrying the pregnancy for the couple.
Couple contracts with a woman to carry a pregnancy using ovum of the woman carrying the pregnancy and donor sperm. Of equal importance to the development of standardized pedigree symbolization is the development of professional guidelines regarding ethical issues in recording a clinical genetic family history, as well as in publication of pedigrees. For instance, in Fig. 5, example 3 Individual with cystic fibrosis and positive mutation study, although only one mutation has currently been identified. where an individual could be identified from the family structure, genetic condition, and the names of the researchers, yet consent for publication may not have been obtained from each person who is symbolized on the pedigree. The development of ethical guidelines about the type of information recorded on a pedigree should be considered. For example, information that is commonly recorded on a pedigree (e.g., same-sex relationships, suicide, alcoholism, HIV status, marital status, pregnancy terminations) may or may not be helpful in making a clinical diagnosis and genetic-risk assessment; however, this type of information, if released to a third party (e.g., insurer, employer), may be used in a discriminatory fashion. The kind of information documented on a pedigree also raises issues of protection of privacy when a family pedigree is exchanged between health professionals evaluating different members of an extended family. The pedigree may contain information not privy to the other relatives (e.g., nonpaternity, pregnancy terminations, affected status, pregnancies conceived by assisted reproductive technologies, etc.). Researchers and clinicians need to weigh carefully patient confidentiality against clinical and genetic relevance when deciding what information to include on a pedigree.
The professional genetics community should continue to explore the many ethical and legal dilemmas surrounding the clinical and research use of the family pedigree, to assure the protection of confidentiality of our patients and subjects. A conference sponsored by the American Association for the Advancement of Science (AAAS)--American Bar Association (ABA) National Conference of Lawyers and Scientists, and the AAAS Committee on Scientific Freedom and Responsibility met to address some of the issues involved in pedigree research but did not arrive at a consensus (Frankel and Teich, 1993) . The Council of Biological Editors has also raised the issue of protection of privacy for individuals in published pedigrees (Glass et al., 1994) . Problems such as misuse of published information, leading to job loss and problems of obtaining life insurance, were addressed. Solutions such as altering or omitting symbols to disguise the family and obtaining consent from each person in a published pedigree were discussed, but no agreement was reached. The professional human genetics societies may wish to consider the development of policy statements to address the issues of confidentiality for subjects in clinical and research pedigrees.
This document is the result of the thoughtful input from many professionals in the genetics community. It is impossible to develop uniform pedigree nomenclature without creating controversy. The problem is succinctly stated by Frances Galton (1889, p. 249), who noted: "There are many methods of drawing pedigrees and describing kinship, but for my own purposes I still prefer those that I designed myself." The proposed recommendations of the PSTF are made as a starting point in the process of adopting uniform pedigree nomenclature. By beginning to use uniform guidelines for pedigree construction in professional publication and clinical and research practice, it is possible to reduce the chances for incorrect interpretation of patient and family medical and genetic information. It may also improve the quality of patient care provided by genetic professionals, as well as facilitate communication between researchers involved with genetic family studies.
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APPENDIX. FICTITIOUS GENETIC FAMILY HISTORY AND PEDIGREE, USING RECOMMENDED PEDIGREE NOMENCLATURE

Clinical Scenario
The consultant, Mrs. Feene O~ype, age 35 years, and her 36-year-old husband, Gene O'Type, are referred to you for genetic counseling regarding advanced maternal age, since Mrs. O'Type is 16 wk into her pregnancy. Mrs. O'Type had one prior pregnancy, an elective termination (TOP) at 18 wk, of a female fetus with trisomy 21.
Mrs. O'Type and Her Side of the Family
• Mrs. O'Type had three prior pregnancies with an ex-husband, the first a TOP, the second a spontaneous abortion (SAB) of a female fetus at
